Journal of Clinical Oncology | 2021

AABH (aspartyl (asparaginyl) β-hydroxylase ) as a serum biomarker for colorectal cancer diagnosis and prognosis.

 
 
 

Abstract


22Background: Colorectal cancer (CRC) is the third most common type of cancer diagnosed in the US. The National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) recommend t...

Volume 39
Pages 22-22
DOI 10.1200/JCO.2021.39.3_SUPPL.22
Language English
Journal Journal of Clinical Oncology

Full Text